ANKARA, Turkey — German pharmaceutical company BioNTech’s CEO Ugur Sahin says Turkey will receive a total of 120 million doses of the Pfizer-BioNTech vaccine by September.

Sahin participated in a meeting of Turkey’s health advisory council via teleconference from Germany. Ozlem Tureci, BioNTech co-founder and Sahin’s wife, also joined the meeting. Both Sahin and Tureci were born to Turkish immigrant parents.

Pfizer-BioNTech agreed in December to provide 30 million doses of its mRNA-based vaccines to Turkey. Under a new agreement that was finalized on Thursday, Turkey will buy 60 million more doses, with an option for an additional 30 million doses.

The Health Ministry posted 9,385 new cases and 207 deaths in the past 24 hours on Thursday. Turkey has registered more than 5.1 million cases and 45,626, confirmed deaths since the start of the pandemic.